Scientists Complete Sequencing Tibetan Antelope Genome
News Dec 28, 2009
BGI and Qinghai University have completed sequencing the genome of Tibetan antelopes, which will hopefully explain the pathogenesis of chronic plateau sickness.
Tibetan antelopes, a peculiar species on China's Qinghai-Tibet Plateau, have been given the highest level of protection under the United Nations' Convention on International Trade in Endangered Species since 1979, and listed among the most endangered species by the Chinese Government since 1988.
They are considered to be ideal species for evolution studies, as they had lived on "the Roof of the World" for millions of years against the backdrop of various environmental extremes, such as extreme cold and low oxygen levels.
"By sequencing the Tibetan antelope genome, we have laid the scientific foundation to decode the pathogenesis of chronic plateau sickness," said Yang Huanming, an academician of the Chinese Academy of Sciences and a participant of the project.
"The studies can also contribute to improving the health of the plateau inhabitants, especially those of Tibetan ethnic group that has lived on the plateau generations after generations," he said.
"Sequencing the Tibetan antelope genome also lays the genetic foundation for us to carry out plateau life sciences studies, but it is only the first step," said Gerili, vice president of the Qinghai University and standing director of the International Society for Mountain Medicine.
"We will further identify the functors on the genome, decode all the genetic information, and explore the genetic basis of Tibetan antelopes' ability to evolve and to adapt to harsh environment," he said.
It is the first genome sequencing of plateau endangered species in the world, he added.
The project was jointly launched by the Qinghai University and BGI, Shenzhen in April this year. In addition to Tibetan antelopes, scientists in BGI are working to sequence the genomes of penguins and polar bears in the project.
Avacta Group plc announces successful outcome of “Gene Delivery” collaboration with FIT BiotechNews
Sustained production of Affimer drugs by muscle tissue in vivo could lead to major patient and commercial benefits.READ MORE
SCRaMbLE Speeds Up Yeast EvolutionNews
Scientists have created a new way of speeding up the genome evolution of baker’s yeast Saccharomyces cerevisiae. This is to develop a synthetic yeast strain that can be transformed on demand, making it industrial applications such as the mass production of advanced medicines to treat illnesses such as malaria and tuberculosis (TB).READ MORE
Artificial Cellular Compartments BuiltNews
How to install new capabilities in cells without interfering with their metabolic processes? A team from the Technical University of Munich (TUM) and the Helmholtz Zentrum München have altered mammalian cells in such a way that they formed artificial compartments in which sequestered reactions could take place, allowing the detection of cells deep in the tissue and also their manipulation with magnetic fields.READ MORE